+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model



Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model



Pain Medicine 17(2): 230-238



This study evaluates the ability of four commonly used analgesics (ketamine HCl, gabapentin, clonidine HCl, and baclofen), when incorporated into two transdermal compounding bases, Lipoderm and Lipoderm ActiveMax, to penetrate human cadaver trunk skin in vitro, using the Franz finite dose model. In vitro experimental study. Methods. Ketamine HCl 5% w/w, gabapentin 10% w/w, clonidine HCl 0.2% w/w, and baclofen 2% w/w were compounded into two transdermal bases, Lipoderm and Lipoderm ActiveMax. Each compounded drug formulation was tested on skin from three different donors and three replicate skin sections per donor. The Franz finite dose model was used in this study to evaluate the percutaneous absorption and distribution of drugs within each formulation. Rapid penetration to peak flux was detected for gabapentin and baclofen at approximately 1 hour after application. Clonidine HCl also had a rapid penetration to peak flux occurring approximately 1 hour after application and had a secondary peak at approximately 40 hours. Ketamine HCl exhibited higher overall absorption rates than the other drugs, and peaked at 6–10 hours. Similar patterns of drug distribution within the skin were also observed using both transdermal bases. This study suggests that the combination of these 4 analgesic drugs can be successfully delivered transdermally, using either Lipoderm or Lipoderm ActiveMax. Compounded transdermal drug preparations may then provide physicians with an alternative to traditional oral pain management regimens that can be personalized to the specific patient with the potential for enhanced pain control.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057817045

Download citation: RISBibTeXText

PMID: 26352507

DOI: 10.1111/pme.12899


Related references

Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model. Postgraduate Medicine 128(2): 262-267, 2016

Near fatal accidental transdermal overdose of compounded ketamine, baclofen, amitriptyline, lidocaine, and ketoprofen A case report. Journal of Toxicology Clinical Toxicology 41(5): 672, August, 2003

Evaluation of ketamine, nimodipine, gabapentin and imipramine in partial sciatic nerve transection model of neuropathic pain in rat: an experimental study. Methods and Findings in Experimental and Clinical Pharmacology 29(7): 443-446, 2007

The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Current Problems in Dermatology 7: 58-68, 1978

Transdermal delivery of indomethacin: II. Effect of penetration enhancers on the in vitro percutaneous absorption from patch formulations. Die Pharmazie 49(8): 619-620, 1994

Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain. Anesthesiology (Hagerstown) 92(4): 1126-1131, 2000

Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain. Anesthesiology 92(4): 1126-1131, 2001

Ex vivo percutaneous absorption of ketamine, bupivacaine, diclofenac, gabapentin, orphenadrine, and pentoxifylline: comparison of versatile cream vs. reference cream. International Journal of Pharmaceutical Compounding 17(6): 520-525, 2014

Intrathecal injection of ketamine and clonidine for chronic neuropathic pain model in rats. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 32(4): 702-705, 2007

Evaluation of a low dose ketamine in post tonsillectomy pain relief: a randomized trial comparing intravenous and subcutaneous ketamine in pediatrics. Anesthesiology and Pain Medicine 2(2): 85-89, 2013

Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial. Pain Physician 13(3): 245-249, 2010

Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations. International Journal of Pharmaceutics 332(1-2): 98-106, 2006

Compounded gabapentin suspension for lower back pain in an older cat: a case report. International Journal of Pharmaceutical Compounding 14(3): 215-217, 2010

Omeprazole absorption from a compounded transdermal formulation in healthy volunteers. Journal of the American Pharmacists Association 45(4): 473-478, 2005

A two-phase two-layer model for transdermal drug delivery and percutaneous absorption. Mathematical Biosciences 257: 96-103, 2015